Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA recruitment-status update was added stating that the study is no longer recruiting participants. This clarifies that enrollment has completed and informs readers about current availability.SummaryDifference0.4%

- Check19 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a new revision of the study record.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing v3.5.3, indicating a new build of the page rendering. No changes to study content are reflected in this update.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page indicates an updated site revision number (from v3.5.2 to v3.5.3). This reflects a versioning update of the page itself rather than a substantive change to the trial information.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated to v3.5.2; the previous v3.5.0 revision was removed.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.